Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Female C57BL/6 mice exhibit protection against nonalcoholic fatty liver disease and diabesity accompanied by differential regulation of hepatic lipocalin prostaglandin D2 synthase.
Islam MA, Khairnar R, Fleishman J, Reznik SE, Ragolia L, Gobbooru S, Kumar S. Islam MA, et al. Among authors: khairnar r. Mol Cell Endocrinol. 2024 Nov 4;595:112404. doi: 10.1016/j.mce.2024.112404. Online ahead of print. Mol Cell Endocrinol. 2024. PMID: 39505230 No abstract available.
Efficacy, Safety and Mechanistic Impact of a Heart Failure Guideline-Directed Medical Therapy Clinic.
Spahillari A, Cohen LP, Lin C, Liu Y, Tringale A, Sheppard KE, Ko C, Khairnar R, Williamson KM, Wasfy JH, Scott NS, Paquette C, Greene SJ, Fonarow GC, Januzzi JL Jr. Spahillari A, et al. Among authors: khairnar r. JACC Heart Fail. 2024 Oct 9:S2213-1779(24)00623-1. doi: 10.1016/j.jchf.2024.08.017. Online ahead of print. JACC Heart Fail. 2024. PMID: 39387769
Comparative effectiveness of sacubitril/valsartan versus angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients with de novo heart failure with mildly reduced and preserved ejection fraction.
Bhatt AS, Vaduganathan M, Jena BP, Suminska S, Eid C, Khairnar R, Farries G, Senni M. Bhatt AS, et al. Among authors: khairnar r. Eur J Heart Fail. 2024 May;26(5):1172-1174. doi: 10.1002/ejhf.3233. Epub 2024 Apr 7. Eur J Heart Fail. 2024. PMID: 38583036 No abstract available.
Methodological Comparison of Mapping the Expanded Prostate Cancer Index Composite to EuroQoL-5D-3L Using Cross-Sectional and Longitudinal Data: Secondary Analysis of NRG/RTOG 0415.
Khairnar R, DeMora L, Sandler HM, Lee WR, Villalonga-Olives E, Mullins CD, Palumbo FB, Bruner DW, Shaya FT, Bentzen SM, Shah AB, Malone S, Michalski JM, Dayes IS, Seaward SA, Albert M, Currey AD, Pisansky TM, Chen Y, Horwitz EM, DeNittis AS, Feng F, Mishra MV. Khairnar R, et al. JCO Clin Cancer Inform. 2022 Jun;6:e2100188. doi: 10.1200/CCI.21.00188. JCO Clin Cancer Inform. 2022. PMID: 35776901 Free PMC article. Clinical Trial.
Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415.
Khairnar R, Pugh SL, Sandler HM, Lee WR, Villalonga Olives E, Mullins CD, Palumbo FB, Bruner DW, Shaya FT, Bentzen SM, Shah AB, Malone SC, Michalski JM, Dayes IS, Seaward SA, Albert M, Currey AD, Pisansky TM, Chen Y, Horwitz EM, DeNittis AS, Feng FY, Mishra MV. Khairnar R, et al. PLoS One. 2021 Apr 14;16(4):e0249123. doi: 10.1371/journal.pone.0249123. eCollection 2021. PLoS One. 2021. PMID: 33852571 Free PMC article. Clinical Trial.
23 results